Previous virtual seminar series

Past dates

• Wednesday 24 April at 16.00 CEST
  Programme is hosted by the group of Edna Grünblatt and it included two talks:
  1) 'Investigating synaptic connectivity in ADHD forebrain cortical neurons (FCNs) and the effects of Methylphenidate' by Cristine Yde Ohki, Switzerland
  2) 'Investigating the functional effects of omega-3 fatty acids against oxidative stress and inflammation in ADHD FCNs' by Natalie Walter, Switzerland

• Wednesday 14 February at 16.00 CET
  Programme was hosted by the group Jeroen Pasterkamp and it included the talk:
  'Investigating the axonal transcriptome of FUS-ALS motor neurons using microfluidic devices' by Anna Wiersima, the Netherlands
  
  
• Wednesday 13 December at 16.00 CET (Central European Time)
  The programme was hosted by the groups of Prof. Kittel-Schneider/Dr. McNeill and Prof. Lesch, from the University Hospital Wuerzburg, Germany, and it included two talks:
  1) 'Investigation of iPSC-derived cortical glutamatergic neurons for glucometabolic dysfunction' by Ana-Magdelina Pineau, Germany
  2) 'Investigation of mitochondrial function in hiPSC-derived models of PARK2 copy number variant carriers with adult ADHD' by Zora Schickardt, Germany
  
  
• Wednesday 18 October at 16.00 CEST
  Programme was hosted by the group of Ágota Apáti and János Réthelyi and it included two talks:
  1) "Transcriptomic comparison of schizophrenia patient-derived iPSC-based hippocampal neurons and CRISPR modified isogenic controls" with Csongor Tordai, Hungary
  2) "Effects of metformin on neurite outgrowth and proliferation in neuronal stem cells derived from DM Type2 patients and healthy controls" with Katalin Vincze, Hungary
  
  
• 16 August at 16.00 CEST (Central European Summer Time)
  Karo Talvio, Finland and Maija L Castren, Finland
  'Human fragile X iPSC-derived cells modeling mechanisms affected in neuropsychiatric disorders'
  
  
• 28 June 2023 at 16.00 CEST (Central European Summer Time)
  Programme was hosted by the group of Tanja Sheldrick-Michel.
  'Using cerebral organoids for studying psychiatric disorders: progress and challenges'.
  
  
• 26 April 2023 at 16.00 CEST (Central European Summer Time)
  Programme was hosted by the group of Luigia Ginetta Collo and it included two talks:
  1) 'Structural plasticity induced by ketamine in human dopaminergic neurons as mechanism relevant for treatment-resistant depression' by Laura Cavalleri, Italy
  2) 'Multiple system atrophy iPSC-derived neurons reveal structural and functional differences from controls' by Giulia Sofia Marcotto, Italy
  
  
• 8 March 2023 at 16.00 CET (Central European Time)
  Programme was hosted by the group of Jeroen Pasterkamp.
  Suzy Varderidou gave a presentation entitled: ‘Amyotrophic Lateral Sclerosis (ALS) propagation through Extracellular Vesicles and treatment strategies.‘
  
  
• 22 February 2023 at 16.00 CET (Central European Time)
  Programme was hosted by the group of Edna Grünblatt.
  Two researchers, Cristine Marie Yde Ohki and Natalie Monet Walter, gave a presentation entitled: 'Investigating the cellular and molecular role of Wnt-pathway across neurodevelopmental processes in health and ADHD- possible modulation via methylphenidate or PUFAs'

• 14 December 2022 at 16.00 CET (Central European Time)
  Programme hosted by the group of Armida Mucci
  ‘Innovative cellular models for schizophrenia: current findings and future approaches’

• 26 October 2022 at 16.00 CEST (Central European Summer Time)
  Programme hosted by the Harwood Group had three talks:
  1) 'Effects of the dietary n-6 PUFAs on human neuronal function' by Karolina Dec, United Kingdom
  2) 'Investigating TSC function with an inducible Cas13' by Laura Kleckner, United Kingdom
  3) 'Kleefstra syndrome and miRNA regulation of NRSF/REST' by Jamie Wood, United Kingdom

• 31 August 2022 at 16.00 CEST (Central European Summer Time)
  The seminar, hosted by Deepak Srivastav's group, had two talks:
  1) 'Analysing early neuronal differentiation in patient-derived induced pluripotent stem cells (iPSC) with NRXN1 mutations' by Lucia Dutan Polit, United Kingdom
  2) 'Translating genetic susceptibility to neurobiology of disease — understanding the role of psychosis risk candidate ZNF804A during synaptic development' by Laura Sichlinger, United Kingdom

• 1 June 2022
  The research group of Oliver Brüstle, Germany, gave two talks on the use of forward-programmed neurons to model candidate genes for neuropsychiatric diseases:
  1) Programmed neuronal subtypes for modeling neuropsychiatric disorders by Michael Peitz
  2) Generation of an isogenic human model of SYNGAP1 syndrome by Christina Au Yeung